News from the healthcare data industry
Karen Ooms, Executive Vice President and Head of Statistics, Quanticate 02.04.22Today more and more pharmaceutical companies are turning to real-world evidence (RWE) to understand the real-life effectiveness of their drug...
Baker McKenzie United Kingdom February 2 2022 NICE has produced a single guidance development manual, which describes how NICE conducts itself with each step and stage in its evaluation (NICE’s processes) and...
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these...
Published on 01/27/2022 By Matthew Franklin, Dan Howdon, Suzanne Mason, Tony Stone, Monica Jones The use of the terms “real-world data” and “real-world evidence” in the context of health decision-making has grown substantially in the last...
Zachary BrennanSenior Editor, Endpoint News Back in late September, the FDA released a long-awaited guidance on how the industry might use electronic health records (EHRs) or medical claims data in...
January 24, 2022 04:12 PM Eastern Standard Time WASHINGTON–(BUSINESS WIRE)–Today, the RWE Alliance submitted a substantial comment letter in response to the U.S. Food and Drug Administration (FDA) draft guidance on using...
By Dr Nicola Davies Since 2020, the US Food and Drug Administration’s activities have centered around the response to the COVID-19 pandemic.1 The agency closed out 2021 with the approval...
by Natalie Missakian | Jan 23, 2022 1:25pm The future of cancer drug marketing will be about helping oncologists understand the complexities of precision medicine and how new advances in targeted therapies can...
Changes to the way medicines and other health technologies are evaluated by NICE for use in the NHS were approved by its Board yesterday (19 January 2022). 20 January 2022...
January 18, 2022Scott Swain, PhD, MPH Since 2016, the 21st Century Cures Act has required the Food and Drug Administration (FDA) to consider the utility of any real-world evidence (RWE)...